Clinical trials
Phase 2 Glucose Metabolism Disorders trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2007 | 2 |
| 2008 | 4 |
| 2009 | 1 |
| 2010 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 1 |
| 2020 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Terminated | 4 |
| Recruiting | 3 |
| Active, not recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Albert Einstein College of Medicine | 4 |
| Takeda | 4 |
| VIVUS LLC | 2 |
| Akcea Therapeutics | 1 |
| Calibra Medical, Inc. | 1 |
| Eli Lilly and Company | 1 |
| Lakewood-Amedex Inc | 1 |
| Meredith Hawkins | 1 |
| Rezolute | 1 |
| Tracey McLaughlin | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glucose Metabolism Disorders | 22 |
| Diabetes Mellitus | 15 |
| Diabetes Mellitus, Type 2 | 11 |
| Metabolic Diseases | 9 |
| Endocrine System Diseases | 7 |
| Insulin Resistance | 5 |
| Diabetes Mellitus, Lipoatrophic | 4 |
| Dyslipidemias | 4 |
| Hypoglycemia | 3 |
| Autoimmune Diseases | 2 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.